Navigation Links
New studies on surgical options in inherited breast cancer show drastic treatment is not always best
Date:3/26/2010

cer recurring in the breast (23.5%) than did patients who had mastectomy (5.5%) at 15 years. But when they looked at patients who had received chemotherapy as well as BCT, they found that the risk of recurrence was much reduced and the overall risk with this treatment was not significantly different from the mastectomy group (11.9%). And despite the higher rates of local recurrence in the BCT group, other risks metastasis, breast cancer-specific survival, and overall survival were similar.

When they compared rates of developing cancer in the unaffected breast, which exceeded 40% in both groups, the researchers found that the use of radiotherapy after surgery did not increase risk in comparison with those women who did not receive radiation treatment.

Although there have been many trials comparing breast conserving surgery and radiotherapy with mastectomy in women with non-hereditary cancer, data on those women with the inherited form of the disease are limited and this has made it difficult for patients and doctors alike to know how best to proceed. Ideally, the researchers say, such studies should be randomised, but because treatments for patients who carry the BRCA1/2 mutation are so individualised and the decision-making so complex, a randomised trial is unlikely.

"To the best of my knowledge, ours is the first multi-institutional systematic comparison of BCT versus mastectomy in BRCA1/2 carriers," Professor Pierce will tell the conference. "It will provide important data to patients trying to decide what will be the best treatment for their hereditary breast cancer, as well as to the doctors advising them.

"If a woman with BRCA1/2-associated breast cancer is considering breast conserving surgery and radiotherapy, our findings show that she will have fewer recurrences in the breast if chemotherapy is also used. And our conclusion that 15-year outcomes of BCT and mastectomy are similar should reassure recently diagnosed wo
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Statement of Ralph B. Everett, President and CEO, Joint Center for Political and Economic Studies, on House Passage of Health Reform Legislation
2. Studies examine Third Eye Retroscope during colonoscopy
3. Studies Show Significant Increases of C. Difficile Infections (CDI)
4. Gays, Lesbians Excluded From Some Medical Studies
5. Most Drug Studies Dont Help Docs Pick Best Treatment
6. Promega - TOP srl Agreement Enables Live Animal Imaging for Cancer Studies
7. COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology
8. Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis
9. Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies
10. UC studies show marijuana has therapeutic value, reports to legislature
11. New Scientific Studies Show Further Evidence of Avandia Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 With ... Josie's Organics, one of the country's leading organic ... minds of moms across the country. What to ... family recipe box or spend hours browsing Pinterest ... on http://www.josiesorganics.com/recipes . , The new ...
(Date:5/5/2015)... RF Technologies®, a leading provider of ... Fall Management Solution with Voice Alarms. The ST750 will ... resident to wait for assistance when it detects them ... of 16 different melodies or tones or silent alerting, ... as Code Alert®. , For 28 years, Sensatec ...
(Date:5/5/2015)... What do you get when you combine ... greatest mountaineers and one of the world’s greatest causes? The ... documentary by Marc Middleton, which follows world-renowned mountaineer Chris Warner ... 19,341-foot frozen summit of Mount Kilimanjaro. , “This film ... to action. Viewers are moved to ask, ‘What can I ...
(Date:5/5/2015)... Sheltering Arms held its annual benefit event ... Cravath, Swaine & Moore LLP for their philanthropic leadership ... was co-chaired by Vanguard sponsors Morgan Stanley and Gail ... Sheltering Arms’ significant growth in New York City and ... Formerly Episcopal Social Services, Sheltering Arms has become of ...
(Date:5/5/2015)... Specialty makeup brand Beauty ... Outfitters on a collection of summer-oriented cosmetics and ... For the debut five-piece summer collection, Beauty For ... Eagle ; the retailer's fast-growing intimates, swim and ... REAL," uses models of various sizes and doesn't ...
Breaking Medicine News(10 mins):Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 2Health News:RF Technologies® Releases Sensatec® ST750 Voice Alarm for Fall Management 3Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 2Health News:LIVESTRONG & Bolder Broadcasting Present Special Edition of Conquering Kilimanjaro 3Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 2Health News:BLKBOXLabs Finds Real Beauty in Beauty For Real and American Eagle Outfitters’ Aerie-Branded Beauty Line 3
... FRAZER, Pa., April 30 Cephalon, Inc. (Nasdaq:,CEPH) ... Executive Vice,President and General Counsel. In this position, ... company, including those relating to commercial,and financial transactions, ... directly to Chairman and CEO, Frank,Baldino Jr., Ph.D., ...
... Pa., April 30 ViroPharma Incorporated,(Nasdaq: VPHM ) reported today ... Key events since December 31, 2007 include:, Development:, ... in stem cell transplant patients that enrollment ... May 2008; -- Patient enrollment continued in Phase 3 study ...
... Fla., April 30 Nihon LocalSoft, a ... the purpose of supporting US,Medical Device Manufactures ... entering the Japanese market, recently helped IRadimed,Corporation ... and localized embedded text for their operating ...
... Teeth,Whitening System(TM) has introduced an FDA cleared teeth ... look of discolored teeth. The company,created the procedure, ... addition to the spa experience. Now the process ... compromising the effectiveness,of the treatment., The Massage ...
... (NYSE: MYL ),today announced that in accordance with ... its quarterly dividend of $16.25 per,share (based on the ... $1,000.00 per share) payable on May 15, 2008, to ... 2008., Mylan Inc., with operations in more than ...
... Warner,Chilcott Limited (Nasdaq: WCRX ) today announced ... a securities class action lawsuit pending,in the United States ... suit asserted claims under the Securities Act of 1933 ... were allegedly damaged as a result of,acquiring the Company,s ...
Cached Medicine News:Health News:Cephalon Appoints Gerald J. Pappert as General Counsel 2Health News:Cephalon Appoints Gerald J. Pappert as General Counsel 3Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 2Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 3Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 4Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 5Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 6Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 7Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 8Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 9Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 10Health News:Nihon LocalSoft Designs New Japanese Software for IRadimed Corporation's Award-Winning MRidium MRI Infusion System 2Health News:Beautiful Teeth Not Just for the Dentist's Office Anymore / SpaBrite Teeth Whitening System(TM) Introduces Innovative, New Teeth Whitening Experience To Spas 2Health News:Warner Chilcott Announces Settlement of Securities Litigation 2Health News:Warner Chilcott Announces Settlement of Securities Litigation 3
(Date:5/5/2015)... , May 5, 2015 Zimmer Holdings, Inc. ... today announced that its Board of Directors has approved the ... second quarter of 2015. The cash dividend of ... 14, 2015, to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
(Date:5/5/2015)... 5, 2015 GW Pharmaceuticals plc (Nasdaq: ... biopharmaceutical company focused on discovering, developing and commercializing ... announced today the closing of the previously announced ... of 1,600,000 American Depositary Shares (ADSs) at a ... of approximately $179.2 million (before deducting underwriting discount, ...
(Date:5/5/2015)... 2015 North American ophthalmology glaucoma ... 2014, and is estimated to grow to $138.3 million ... to 2019. Browse through the TOC of ... analysis of industry trends and segments, with the help ... Early buyers will receive 10% ...
Breaking Medicine Technology:GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3
... WATERTOWN, Mass.--(BUSINESS WIRE)--May 29, 2007 - Panacos,Pharmaceuticals, ... the next generation of antiviral,therapeutic products, today ... that HIV resistant to Protease Inhibitors (PI) ... resistance to the HIV,maturation inhibitor bevirimat in ...
... Taxotere(R) and on three investigational,agents (VEGF Trap, S-1 ... ASCO meeting, BRIDGEWATER, N.J., May 29, 2007 /PRNewswire-FirstCall/ ... abstracts,indicative of its oncology commitment have been accepted ... of Clinical Oncology,(ASCO) in Chicago, Illinois (June 1-5, ...
Cached Medicine Technology:Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 2Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have,Reduced Potential to Develop Resistance to Panacos' Bevirimat 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 2Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 3Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 4Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 5Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 6Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 7Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 8Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 9Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 10Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 11Data to be Presented at ASCO 2007 Highlights sanofi-aventis,Commitment to Cancer Care and Research 12
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Seldin periosteal elevator #23, flat handle, 19.5 cm, 7-3/4"....
The CD Horizon Antares Spinal System represent a new addition to the CD Horizon Spinal System. It is based around a new, anatomically designed "pringle shaped" staple that allows for the placement of...
... a universal hook, rod, and screw system designed ... Moss Miami system utilizes a low profile design ... dual closure mechanism. The load sharing design of ... band principle to be applied when used with ...
Medicine Products: